Topic: How To Invest

What can you tell me about Paladin Labs (PLB)? Thank you.

Article Excerpt

Paladin Labs, $26.75, symbol PLB on Toronto (Shares outstanding: 18.7 million; Market cap: $501.0 million), is a Montreal-based specialty pharmaceutical company. Paladin sells its drugs to Canadian doctors who focus on urology, dermatology, pain management and women’s health. Paladin mainly buys, licenses and markets drugs. It specializes in drugs with patents that are about to expire, and under-promoted drugs from large pharmaceutical companies, like Wyeth, Johnson & Johnson, Eli Lilly, Novartis and Pfizer. Paladin also buys new drugs, or those that are close to having their patents approved. It mainly gets these drugs from small- to medium-sized pharmaceutical and biotechnology companies with no sales or marketing presence in Canada. Paladin promotes seven key brands, including Twinject, a pre-filled, pen-sized auto-injector with two doses of epinephrine for the emergency treatment of allergic reactions; Metadol and Tridural (both of which treat chronic pain); Pennsaid (for arthritis); Testim (a testosterone gel); Seasonale (a birth-control pill); and Plan B (an emergency contraceptive that is effective up…